Hietanen, Eero
Tripathi, Lav
Brockmann, Eeva-Christine
Merilahti, Pirjo
Lamminmäki, Urpo
Susi, Petri
Funding for this research was provided by:
Turku Doctoral Programme of Molecular Medicine
Foundation for Research of Viral Diseases
Alfred Kordelinin Säätiö
Oskar Öflunds Stiftelse
AIROPico, FP7-PEOPLE-2013-IAPP (612308)
Business Finland
Turun Yliopistollinen Keskussairaala
Article History
Received: 7 May 2022
Accepted: 29 July 2022
First Online: 4 August 2022
Competing interests
: The authors declare no competing interests. ScFv antibodies described in this article are a property of University of Turku, Turku, Finland.